Cost Savings in Dermatology: Comparing CostPlus and GoodRx
Author Information
Author(s): Christopher G Youn, Joo Yeon Kim, Vivian B Yang, Gordon H Bae
Primary Institution: Stanford University School of Dermatology
Hypothesis
Does the Mark Cuban Cost Plus Drug Company provide significant cost savings compared to GoodRx for dermatology medications?
Conclusion
The Mark Cuban Cost Plus Drug Company offers significantly lower medication costs compared to GoodRx, resulting in greater savings for patients.
Supporting Evidence
- CostPlus offers medications at a 15% markup plus a $5 pharmacy fee, leading to significant savings.
- The average medication cost through CostPlus was $17 compared to $31.21 through GoodRx.
- CostPlus resulted in average savings of $130.23 (81%) compared to GoodRx's $116.01 (70%).
Takeaway
This study shows that using CostPlus can save people a lot of money on skin medicine compared to another service called GoodRx.
Methodology
An observational cost analysis comparing medication prices from CostPlus and GoodRx in major US cities.
Potential Biases
The study may not be generalizable as CostPlus is a unique model in the US.
Limitations
The study is observational, assessed prices at a single time point, and did not evaluate the impact of ordering multiple medications or prices from compounding pharmacies.
Participant Demographics
The study highlights issues particularly affecting uninsured individuals and those with high-deductible health plans.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website